DekaBank Deutsche Girozentrale’s Regenxbio RGNX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$577K	Hold	74,600	–	–	﹤0.01%	862
2026 Q1	$589K	Hold	74,600	–	–	﹤0.01%	862
2025 Q4	$1.8M	Hold	74,600	–	–	﹤0.01%	787
2025 Q3	$728K	Hold	74,600	–	–	﹤0.01%	925
2025 Q2	$622K	Hold	74,600	–	–	﹤0.01%	942
2025 Q1	$572K	Hold	74,600	–	–	﹤0.01%	949
2024 Q4	$546K	Hold	74,600	–	–	﹤0.01%	987
2024 Q3	$795K	Hold	74,600	–	–	﹤0.01%	928
2024 Q2	$864K	Hold	74,600	–	–	﹤0.01%	907
2024 Q1	$1.64M	Hold	74,600	–	–	﹤0.01%	796
2023 Q4	$1.38M	Buy	74,600 +37,000	+98%	+$652K	﹤0.01%	848
2023 Q3	$661K	Hold	37,600	–	–	﹤0.01%	955
2023 Q2	$743K	Hold	37,600	–	–	﹤0.01%	941
2023 Q1	$674K	Hold	37,600	–	–	﹤0.01%	956
2022 Q4	$851K	Hold	37,600	–	–	﹤0.01%	918
2022 Q3	$928K	Hold	37,600	–	–	﹤0.01%	890
2022 Q2	$904K	Hold	37,600	–	–	﹤0.01%	899
2022 Q1	$1.24M	Buy	37,600 +3,400	+10%	+$94.4K	﹤0.01%	868
2021 Q4	$1.11M	Buy	34,200 +900	+3%	+$30.6K	﹤0.01%	916
2021 Q3	$1.4M	Sell	33,300 -20,000	-38%	-$720K	﹤0.01%	816
2021 Q2	$2.03M	Hold	53,300	–	–	0.01%	718
2021 Q1	$1.78M	Hold	53,300	–	–	0.01%	732
2020 Q4	$2.47M	Sell	53,300 -22,700	-30%	-$793K	0.01%	621
2020 Q3	$2.09M	Buy	+76,000	New	+$2.48M	0.01%	585
2019 Q3	–	Sell	-6,800	Closed	-$338K	–	1096
2019 Q2	$338K	Sell	6,800 -16,900	-71%	-$844K	﹤0.01%	963
2019 Q1	$1.74M	Buy	23,700 +4,300	+22%	+$213K	0.01%	634
2018 Q4	$804K	Sell	19,400 -4,300	-18%	-$252K	0.01%	738
2018 Q3	$1.74M	Sell	23,700 -600	-2%	-$43.2K	0.01%	647
2018 Q2	$1.75M	Buy	24,300 +12,000	+98%	+$573K	0.01%	616
2018 Q1	$361K	Buy	+12,300	New	+$358K	﹤0.01%	916

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DekaBank Deutsche Girozentrale's RGNX Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Regenxbio (RGNX) position steady in Q2 2026 at 74,600 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #862.

DekaBank Deutsche Girozentrale first reported a position in RGNX in Q1 2018 and has held it in 30 quarters since. The position peaked at $2.47M in Q4 2020. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

DekaBank Deutsche Girozentrale held 74,600 shares of Regenxbio worth $577K as of Q2 2026.
DekaBank Deutsche Girozentrale left its Regenxbio share count unchanged in Q2 2026.
Regenxbio made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #862 holding.
DekaBank Deutsche Girozentrale first reported a position in Regenxbio in Q1 2018 and has held it in 30 quarters since.
DekaBank Deutsche Girozentrale's Regenxbio position peaked at $2.47M in Q4 2020.
165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.